Illumina, Boehringer Ingelheim to develop companion diagnostics for oncology products
As part of the first programme, the companies will develop a CDx for a Boehringer Ingelheim investigational medicine
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
As part of the first programme, the companies will develop a CDx for a Boehringer Ingelheim investigational medicine
Kiestra IdentifA system is developed for the automation of the preparation of microbiology bacterial identification testing
By using the Scanwell Health mobile app, the rapid self-test will interpret and deliver a digital display of…
The LUNAR-2 blood test has been developed for the screening of average-risk patients for colorectal cancer
CGP test provides comprehensive information in a single test, as well as information on complex genomic signatures such…
The funding will be used by the company to address the increasing demand for its advanced connected chronic…
The new digital therapeutic enables patients to watch therapeutically modified TV shows and movies to enhance their vision…
The rapid microfluidic immunofluorescence assay will facilitate the simultaneous identification of SARS-CoV-2, Influenza A, and Influenza B viral…
Oregon is said to be the first US state to implement GE Healthcare’s new statewide command center software…
Bongo Rx is simply inserted in the nostrils during sleep to create a seal to keep air flowing…